When Roche announced last month that it planned to acquire nanopore sequencing startup Genia for up to $350 million, unbeknownst to the public it had already struck an agreement with another firm with a potentially complementary sequencing chemistry – Stratos Genomics.
Roche announced today, it made a strategic investment in Stratos Genomics and entered into a research collaboration to support further development of their unique chemistry applied to single molecule sequencing of DNA fragments using protein nanopores.
Stratos Genomics is in the midst of a Series B funding round in which it hopes to raise at least $15 million by the end of March to develop a low-cost sequencing platform that combines the speed and throughput of nanopores with improved resolution and signal to noise, both for targeted and whole-genome sequencing.
Stratos Genomics today announced it has achieved a break-through in the reduction of the SBX™ (Sequencing by Expansion™) probe library. The original commercialization path for SBX was a 256 tetramer probe library.
Stratos Genomics Inc today announced that it has reached its next significant milestone by achieving single molecule DNA sequencing of 100+ base templates with its patented “Sequencing by Expansion™” (SBX) technology. Stratos Genomics also announced the addition of Tim Hunkapiller, co-inventor of four-color Sanger sequencing, to its Science Advisory Board (SAB).
Stratos Genomics today announced the closing of $2 million to support continued development and strategic discussions related to Stratos’ ultra low cost method of DNA sequencing called “Sequencing by Expansion™” (SBX™).